Browse the corpus

REFERENCES American College of Rheumatology Ad Hoc Committee on Clinical Guidelines, “Guidelines for Monitoring Drug Therapy in Rheumatoid Arthritis,” Arthritis Rheum , 1996, 39(5):723-31. [PubMed 8639168 ] Anstey AV, Wakelin S, and Reynolds NJ, “Guidelines for Prescribing Azathioprine in Dermatology,” Br J Dermatol , 2004, 151(6):1123-32. [PubMed 15606506 ] Arnold DM, Nazi I, Santos A, et al, “Combination Immunosuppressant Therapy for Patients With Chronic Refractory Immune Thrombocytopenic Purpura,” Blood , 2010, 115(1):29-31. [PubMed 19897578 ] Aronoff GR, Bennett WM, Berns JS, et al, Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children , 5th ed. Philadelphia, PA: American College of Physicians; 2007, p 97, 177. Baum D, Bernstein D, Starnes VA, et al, “Pediatric Heart Transplantation at Stanford: Results of a 15-Year Experience,” Pediatrics , 1991, 88(2):203-14. [PubMed 1861916 ] Beissert S, Werfel T, Frieling U, et al, "A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus," Arch Dermatol , 2006, 142(11):1447-54. [PubMed 17116835 ] Boruchov DM, Gururangan S, Driscoll MC, et al, “Multiagent Induction and Maintenance Therapy for Patients With Refractory Immune Thrombocytopenic Purpura (ITP),” Blood , 2007, 110(10):3526-31. [PubMed 17698634 ] Briemberg HR and Amato AA, “Dermatomyositis and Polymyositis,” Curr Treat Options Neurol , 2003, 5(5):349-56. [PubMed 12895397 ] Brookes MJ and Green JR, “Maintenance of Remission in Crohn's Disease: Current and Emerging Therapeutic Options,” Drugs , 2004, 64(10):1069-89. [PubMed 15139787 ] Cheble JM, Gaburri PD, De Souza AF, et al, “Long-Term Results With Azathioprine Therapy in Patients With Corticosteroid-Dependent Crohn's Disease: Open-Label Prospective Study,” J Gastroenterol Hepatol , 2007, 22(2):268-74. [PubMed 17295882 ] Hahn BH, McMahon MA, Wilkinson A, et al, "American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis," Arthritis Care Res (Hoboken) , 2012, 64(6):797-808. [PubMed 22556106 ] Houssiau FA, D'Cruz D, Sangle S, “Azathioprine versus Mycophenolate Mofetil for Long-Term Immunosuppression in Lupus Nephritis: Results from the MAINTAIN Nephritis Trial,” Ann Rheum Dis , 2010, 69(12):2083-9. [PubMed 20833738 ]

Hahn BH, McMahon MA, Wilkinson A, et al, "American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis," Arthritis Care Res (Hoboken) , 2012, 64(6):797-808. [PubMed 22556106 ] Houssiau FA, D'Cruz D, Sangle S, “Azathioprine versus Mycophenolate Mofetil for Long-Term Immunosuppression in Lupus Nephritis: Results from the MAINTAIN Nephritis Trial,” Ann Rheum Dis , 2010, 69(12):2083-9. [PubMed 20833738 ] Johnson CA and Porter WA, “Compatibility of Azathioprine Sodium With Intravenous Fluids,” Am J Hosp Pharm , 1981, 38(6):871-5. [PubMed 7246562 ] Jones RR, "Azathioprine Therapy in the Management of Persistent Erythema Multiforme," Br J Dermatol , 1981, 105(4):465-7. [PubMed 7295560 ] Kornbluth A and Sachar DB, “Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee,” Am J Gastroenterol , 2010, 105(3):501-23. [PubMed 20068560 ] Lichtenstein GR, Abreu MT, Cohen R, et al, “American Gastroenterological Association Institute Medical Position Statement on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease,” Gastroenterology , 2006, 130(3):935-9. [PubMed 16530531 ] Lichtenstein GR, Hanauer SB, and Sandborn WJ, “Management of Crohn's Disease in Adults,” Am J Gastroenterol , 2009, 104(2):465-83. [PubMed 19174807 ] Matalon ST, Ornoy A, and Lishner M, et al, “Review of the \Potential Effects of Three Commonly Used Antineoplastic and Immunosuppressive Drugs (Cyclophosphamide, Azathioprine, Doxorubicin on the Embryo and Placenta),” Reprod Toxicol , 2004, 18(2):219-30. [PubMed 15019720 ] Moroni G, Doria A, Mosca M, et al, “A Randomized Pilot Trial Comparing Cyclosporine and Azathioprine for Maintenance Therapy in Diffuse Lupus Nephritis Over Four Years,” Clin J Am Soc Nephrol , 2006, 1(5):925-32. [PubMed 17699309 ] National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Parakkal D, Sifuentes H, Semer R, et al, “Hepatosplenic T-Cell Lymphoma in Patients Receiving TNF-α Inhibitor Therapy: Expanding the Groups at Risk,” Eur J Gastroenterol Hepatol , 2011, 23(12):1150-6. [PubMed 21941193 ] Petri M, “Immunosuppressive Drug Use in Pregnancy,” Autoimmunity , 2003, 36(1):51-6. [PubMed 12765471 ]

National Institute for Occupational Safety and Health (NIOSH), "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012." Available at file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf . Accessed January 21, 2013. Parakkal D, Sifuentes H, Semer R, et al, “Hepatosplenic T-Cell Lymphoma in Patients Receiving TNF-α Inhibitor Therapy: Expanding the Groups at Risk,” Eur J Gastroenterol Hepatol , 2011, 23(12):1150-6. [PubMed 21941193 ] Petri M, “Immunosuppressive Drug Use in Pregnancy,” Autoimmunity , 2003, 36(1):51-6. [PubMed 12765471 ] Sandborn WJ, “A Review of Immune Modifier Therapy for Inflammatory Bowel Disease: Azathioprine, 6-mercaptopurine, Cyclosporine, and Methotrexate,” Am J Gastroenterol , 1996, 91(3):423-33. [PubMed 8633486 ] Simon L, Lipman AG, Jacox A, et al, “Guideline for the Management of Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis Pain,” 2nd ed, Glenview IL, American Pain Society, 2002. Wiendl H, Toyka KV, Rieckmann P, et al, “Basic and Escalating Immunomodulatory Treatments in Multiple Sclerosis: Current Therapeutic Recommendations,” J Neurol , 2008, 255(10):1449-63. [PubMed 19005625 ] Topic 9026 Version 45.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1104-122.72.76.133-9E6425AB09-S244013.14]